StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
49
This month
2
This year
8
Publishing Date
2024 - 04 - 17
1
2024 - 04 - 09
1
2024 - 03 - 26
1
2024 - 02 - 22
1
2024 - 02 - 20
1
2024 - 02 - 01
2
2024 - 01 - 21
1
2023 - 12 - 04
1
2023 - 12 - 03
1
2023 - 11 - 27
1
2023 - 11 - 22
1
2023 - 11 - 15
1
2023 - 11 - 07
1
2023 - 08 - 31
1
2023 - 08 - 23
1
2023 - 08 - 22
1
2023 - 08 - 15
1
2023 - 07 - 26
1
2023 - 06 - 21
1
2023 - 05 - 30
1
2023 - 05 - 09
1
2023 - 05 - 02
1
2023 - 04 - 25
1
2023 - 04 - 04
1
2023 - 03 - 15
1
2023 - 03 - 14
1
2023 - 03 - 08
1
2023 - 02 - 16
1
2023 - 01 - 24
1
2023 - 01 - 09
1
2022 - 12 - 29
1
2022 - 11 - 07
1
2022 - 10 - 25
1
2022 - 10 - 13
1
2022 - 09 - 26
1
2022 - 09 - 20
1
2022 - 08 - 25
1
2022 - 07 - 06
1
2022 - 06 - 22
1
2022 - 06 - 14
1
2022 - 06 - 02
1
2022 - 05 - 26
1
2022 - 04 - 27
1
2022 - 04 - 07
1
2022 - 03 - 14
1
2022 - 01 - 28
1
2022 - 01 - 05
1
2022 - 01 - 04
1
Sector
Health technology
49
Tags
Agreement
1
Alzheimer
1
Alzheimer's
1
Alzheimer’s
3
Animal
1
Application
1
Approval
1
Ath434
22
Australia
2
Authorization
4
Biomarker
1
Conference
3
Congress
1
Disease
8
Disorders
1
Drug
2
Europe
2
Fda
1
Flow
8
Fy22
3
Fy23
4
Fy24
2
Global
1
Grant
1
Granted
2
House
1
International
2
Key
1
License
1
Life
1
Meeting
6
Million
1
Mst
1
N/a
65
Natural
3
Neurodegenerative
2
Neurological
1
Neurology
1
Order
1
Parkinson
2
Parkinson’s
6
Patent
4
Phase 2
16
Pipeline
1
Positive
1
Presentation
7
Rare
4
Report
9
Research
2
Sciences
1
Sensor
3
Study
7
System
15
Therapeutics
49
Train
1
Treatment
6
Trial
16
Usa
1
Week
1
World
1
Entities
Alterity therapeutics limited
49
Symbols
ATHE
49
Exchanges
Nasdaq
49
Crawled Date
2024 - 04 - 17
1
2024 - 04 - 09
1
2024 - 03 - 26
1
2024 - 02 - 23
1
2024 - 02 - 20
1
2024 - 02 - 01
2
2024 - 01 - 22
1
2023 - 12 - 04
2
2023 - 11 - 27
1
2023 - 11 - 22
1
2023 - 11 - 15
1
2023 - 11 - 08
1
2023 - 08 - 31
1
2023 - 08 - 23
1
2023 - 08 - 22
1
2023 - 08 - 15
1
2023 - 07 - 26
1
2023 - 06 - 21
1
2023 - 05 - 30
1
2023 - 05 - 10
1
2023 - 05 - 03
2
2023 - 04 - 04
1
2023 - 03 - 16
1
2023 - 03 - 14
1
2023 - 03 - 08
1
2023 - 02 - 16
1
2023 - 01 - 24
1
2023 - 01 - 09
1
2022 - 12 - 29
1
2022 - 11 - 07
1
2022 - 10 - 26
1
2022 - 10 - 13
1
2022 - 09 - 26
1
2022 - 09 - 20
1
2022 - 08 - 25
1
2022 - 07 - 06
1
2022 - 06 - 23
1
2022 - 06 - 14
1
2022 - 06 - 02
1
2022 - 05 - 26
1
2022 - 04 - 27
1
2022 - 04 - 07
1
2022 - 03 - 15
1
2022 - 01 - 28
1
2022 - 01 - 06
2
Crawled Time
00:00
12
01:00
6
02:00
8
03:00
6
04:00
2
05:00
6
06:00
2
08:00
1
13:27
2
23:00
4
Source
acertx.com
1
akaritx.com
4
alteritytherapeutics.com
49
arcturusrx.com
1
atossatherapeutics.com
2
feed.businesswire.com
12
investors.biomarin.com
1
investors.senseibio.com
3
ir.agiletherapeutics.com
16
ir.akerotx.com
25
ir.biolinerx.com
1
ir.catabasis.com
1
ir.cleverleaves.com
1
ir.cyclerion.com
15
ir.hoththerapeutics.com
17
ir.stockpr.com
4
ir.therapeuticsmd.com
3
ir.trevitherapeutics.com
5
ir.vistagen.com
4
ir.voyagertherapeutics.com
28
ir.vtvtherapeutics.com
6
jaguarhealth.gcs-web.com
7
neurosense.investorroom.com
14
nutriband.com
1
seelostherapeutics.com
1
spacfeed.com
50
werewolftx.com
3
www.4dpharmaplc.com
1
www.acertx.com
4
www.allogene.com
20
www.alnylam.com
1
www.appliedtherapeutics.com
1
www.aquestive.com
29
www.arcutis.com
3
www.atossatherapeutics.com
7
www.biospace.com
3914
www.canopygrowth.com
2
www.catalent.com
1
www.cidara.com
2
www.cowen.com
1
www.cuebiopharma.com
1
www.curevac.com
1
www.globenewswire.com
4412
www.halozyme.com
1
www.immunoprecise.com
1
www.invobioscience.com
1
www.jupiterwellnessinc.com
1
www.prnewswire.com
896
www.respirerx.com
1
www.rubiustx.com
1
www.sutrobio.com
1
www.travere.com
2
www.voyagertherapeutics.com
3
www.vynetherapeutics.com
21
www.zailaboratory.com
1
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Therapeutics
source :
Alteritytherapeutics.com
save search
Alterity Therapeutics Parkinson’s Disease and Multiple System Atrophy Data Featured at the American Academy of Neurology (AAN) 2024 Annual Meeting
Published:
2024-04-17
(Crawled : 01:00)
- alteritytherapeutics.com
ATHE
|
$2.13
0.47%
33K
|
Health Technology
|
3.9%
|
O:
0.0%
H:
7.32%
C:
-1.95%
disease
neurology
system
meeting
parkinson’s
therapeutics
Alterity Therapeutics to Present New Data on ATH434 at the World Orphan Drug Congress USA 2024
Published:
2024-04-09
(Crawled : 23:00)
- alteritytherapeutics.com
ATHE
|
$2.13
0.47%
33K
|
Health Technology
|
11.52%
|
O:
1.05%
H:
22.28%
C:
13.47%
ath434
drug
congress
world
therapeutics
usa
Alterity Therapeutics Receives a $3.9 million Research & Development Tax Incentive Refund
Published:
2024-03-26
(Crawled : 04:00)
- alteritytherapeutics.com
ATHE
|
$2.13
0.47%
33K
|
Health Technology
|
24.56%
|
O:
2.34%
H:
5.11%
C:
2.86%
million
research
therapeutics
Alterity Therapeutics Raises $3.25 M AUD in Placement
Published:
2024-02-22
(Crawled : 00:00)
- alteritytherapeutics.com
ATHE
|
$2.13
0.47%
33K
|
Health Technology
|
4.41%
|
O:
-11.76%
H:
5.56%
C:
-5.0%
therapeutics
Alterity Therapeutics to Present New Data at the Upcoming American Academy of Neurology 2024 Annual Meeting
Published:
2024-02-20
(Crawled : 02:00)
- alteritytherapeutics.com
ATHE
|
$2.13
0.47%
33K
|
Health Technology
|
4.41%
|
O:
-1.96%
H:
4.0%
C:
1.5%
meeting
therapeutics
Alterity Therapeutics Successfully Completes Securities Purchase Plan (SPP)
Published:
2024-02-01
(Crawled : 23:00)
- alteritytherapeutics.com
ATHE
|
$2.13
0.47%
33K
|
Health Technology
|
0.0%
|
O:
0.0%
H:
0.0%
C:
-2.35%
therapeutics
Alterity Therapeutics to Participate in the ShareCafe Hidden Gems Webinar This Week
Published:
2024-02-01
(Crawled : 05:00)
- alteritytherapeutics.com
ATHE
|
$2.13
0.47%
33K
|
Health Technology
|
0.95%
|
O:
6.16%
H:
0.0%
C:
-4.91%
week
therapeutics
Alterity Therapeutics Issues Shareholder Letter Highlighting Pipeline Advances and Key Upcoming Milestones
Published:
2024-01-21
(Crawled : 00:00)
- alteritytherapeutics.com
ATHE
|
$2.13
0.47%
33K
|
Health Technology
|
14.52%
|
O:
1.08%
H:
3.19%
C:
-1.6%
pipeline
key
therapeutics
Alterity Therapeutics to Host Webcast to Discuss ATH434 Efficacy Data in Primates and Recent Clinical Progress
Published:
2023-12-04
(Crawled : 06:00)
- alteritytherapeutics.com
ATHE
|
$2.13
0.47%
33K
|
Health Technology
|
28.31%
|
O:
156.02%
H:
27.29%
C:
-1.18%
ath434
therapeutics
Alterity Therapeutics Reports Positive Efficacy Data for ATH434 in a Primate Model of Parkinson’s Disease
Published:
2023-12-03
(Crawled : 00:00)
- alteritytherapeutics.com
ATHE
|
$2.13
0.47%
33K
|
Health Technology
|
28.31%
|
O:
156.02%
H:
27.29%
C:
-1.18%
ath434
disease
positive
parkinson’s
therapeutics
Alterity Therapeutics Announces Presentation of Novel Biomarker Data for Evaluation of Multiple System Atrophy
Published:
2023-11-27
(Crawled : 05:00)
- alteritytherapeutics.com
ATHE
|
$2.13
0.47%
33K
|
Health Technology
|
15.14%
|
O:
-7.03%
H:
0.58%
C:
0.58%
biomarker
presentation
system
therapeutics
Alterity Therapeutics Raises $4.8M AUD in Placement
Published:
2023-11-22
(Crawled : 06:00)
- alteritytherapeutics.com
ATHE
|
$2.13
0.47%
33K
|
Health Technology
|
Email alert
Add to watchlist
therapeutics
Alterity Therapeutics Announces Presentation of New Data Demonstrating Novel Mechanisms of ATH434
Published:
2023-11-15
(Crawled : 23:00)
- alteritytherapeutics.com
ATHE
|
$2.13
0.47%
33K
|
Health Technology
|
-13.03%
|
O:
-2.0%
H:
0.56%
C:
-2.08%
ath434
presentation
therapeutics
Alterity Therapeutics Completes Enrolment in ATH434-201 Phase 2 Clinical Trial in Multiple System Atrophy
Published:
2023-11-07
(Crawled : 00:00)
- alteritytherapeutics.com
ATHE
|
$2.13
0.47%
33K
|
Health Technology
|
-9.36%
|
O:
5.96%
H:
8.43%
C:
6.43%
ath434
system
trial
therapeutics
phase 2
Alterity Therapeutics Presents New Data on Multiple System Atrophy, a Rare Parkinsonian Disorder
Published:
2023-08-31
(Crawled : 01:00)
- alteritytherapeutics.com
ATHE
|
$2.13
0.47%
33K
|
Health Technology
|
-22.55%
|
O:
0.0%
H:
0.0%
C:
-1.09%
rare
system
therapeutics
Alterity Therapeutics Granted New Composition of Matter Patent in Europe for Neurodegenerative Diseases including Parkinson’s and Alzheimer’s
Published:
2023-08-23
(Crawled : 05:00)
- alteritytherapeutics.com
ATHE
|
$2.13
0.47%
33K
|
Health Technology
|
-23.93%
|
O:
2.14%
H:
0.0%
C:
-2.09%
europe
patent
granted
alzheimer’s
parkinson’s
therapeutics
neurodegenerative
Alterity Therapeutics Rare Disease Natural History Study to be Featured at the International Congress of Parkinson’s Disease and Movement Disorders
Published:
2023-08-22
(Crawled : 08:00)
- alteritytherapeutics.com
ATHE
|
$2.13
0.47%
33K
|
Health Technology
|
-21.11%
|
O:
0.0%
H:
3.93%
C:
3.7%
rare
disease
natural
international
disorders
parkinson’s
therapeutics
study
Alterity Therapeutics Receives a $4.74 million Research & Development Tax Incentive Refund
Published:
2023-08-15
(Crawled : 02:00)
- alteritytherapeutics.com
ATHE
|
$2.13
0.47%
33K
|
Health Technology
|
-25.52%
|
O:
0.35%
H:
0.0%
C:
-2.44%
research
therapeutics
Alterity Therapeutics Phase 2 Data Monitoring Committee Recommends Continuing Clinical Trial as Planned
Published:
2023-07-26
(Crawled : 00:00)
- alteritytherapeutics.com
ATHE
|
$2.13
0.47%
33K
|
Health Technology
|
-23.1%
|
O:
2.89%
H:
5.8%
C:
3.5%
trial
therapeutics
phase 2
Alterity Therapeutics to Present in MST Access Rare Diseases, Rich Returns Forum on 22 June 2023
Published:
2023-06-21
(Crawled : 00:00)
- alteritytherapeutics.com
ATHE
|
$2.13
0.47%
33K
|
Health Technology
|
-26.55%
|
O:
0.34%
H:
0.0%
C:
-1.72%
rare
mst
therapeutics
← Previous
1
2
3
Next →
Gainers vs Losers
78%
22%
Top 10 Gainers
MTTR
|
News
4
|
$4.6
164.37%
62.17%
26M
|
AGBA
|
$2.97
137.6%
57.48%
66M
|
Finance
EDBL
|
News
|
$6.59
75.27%
41.8%
2M
|
ZAPP
|
$4.44
50.2%
33.12%
370K
|
n/a
MTC
|
$2.24
43.59%
30.67%
6M
|
Technology Services
OPRT
|
News
|
$3.15
40.0%
29.13%
12M
|
Finance
SHIM
|
$3.045
35.33%
26.23%
870K
|
HKIT
|
$1.33
30.39%
24.16%
390K
|
Technology Services
ABVC
|
$1.35
29.81%
23.53%
7.1M
|
Wholesale Trade
OST
|
$0.5
25.0%
21.88%
280K
|
Your saved searches
Save your searches and get alerts when important news are released.